BridgeMD
New treatment option for Acute Respiratory Failure
Official title Continous Positive Airway Pressure (CPAP) Support for Acute Hypoxemic Respiratory Failure in Burkina Faso
ClinicalTrials.gov ID: NCT06912360
What this study is testing
- What it's testing
- Acute respiratory failure (ARF) is a frequent medical emergency, involving high costs for health organizations and patients who often require intensive care and respiratory assistance. According to an international study, 61% of hypoxemic patients in intensive care receive invasive ventilation [3].
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All patients aged 18 years and older will be included in the study if they meet at least one of the following criteria :
- Acute respiratory distress, defined as dyspnea respiratory rate ≥ 25 cycles/min
- Hypoxemia, defined as the need for more 6 liters of oxygen to maintain an oxygen saturation (SpO2) of ≥ 92%. The fraction of inspired oxygen (FiO2)...
You likely can't join if
- Patients with any of the following criteria will not be included in the study:
- Pregnant or breastfeeding women
- Persons deprived of their liberty
- Exacerbation of asthma, chronic obstructive pulmonary disease, or another chronic respiratory disease
- Moderate to large amount of unilateral or bilateral undrained pleural effusion
- Contraindication to CPAP: patient refusal, undrained pneumothorax, chest injury, repeated or large vomiting, upper gastrointestinal bleeding...
See the full eligibility criteria
- All patients aged 18 years and older will be included in the study if they meet at least one of the following criteria :
- Acute respiratory distress, defined as dyspnea respiratory rate ≥ 25 cycles/min
- Hypoxemia, defined as the need for more 6 liters of oxygen to maintain an oxygen saturation (SpO2) of ≥ 92%. The fraction of inspired oxygen (FiO2) will be estimated using the 3% rule.
- Patients with any of the following criteria will not be included in the study:
- Pregnant or breastfeeding women
- Persons deprived of their liberty
- Exacerbation of asthma, chronic obstructive pulmonary disease, or another chronic respiratory disease
- Moderate to large amount of unilateral or bilateral undrained pleural effusion
- Contraindication to CPAP: patient refusal, undrained pneumothorax, chest injury, repeated or large vomiting, upper gastrointestinal bleeding, craniofacial trauma, severe upper airway obstruction, or tetraplegia in the...
- Cardiac arrest, severe arrhythmias, shock requiring the use of vasopressors (norepinephrine, adrenaline, dopamine)
- Altered level of consciousness (Glasgow Coma Scale score \< 13), repeated seizures, or status epilepticus
- Medical decision to limit treatment: no intubation, no admission to intensive care
- Refusal to participate in the study or participation in another treatment study on respiratory distress or acute respiratory failure.
The study team makes the final eligibility decision.
Where it's taking place
- Bobo-Dioulasso, Houet, Burkina Faso
- Ouagadougou, Kadiogo, Burkina Faso
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bobo-Dioulasso, Houet, Burkina Faso; Ouagadougou, Kadiogo, Burkina Faso. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.